Cardiac Drugs in Pregnancy
(Sprache: Englisch)
Covering the latest research on treating cardiovascular disease during pregnancy as well as postpartum, this study discusses the indications of drug usage in pregnant women and assesses the risks and benefits of a range of therapies in the relevant population.
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
48.14 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
Produktdetails
Produktinformationen zu „Cardiac Drugs in Pregnancy “
Covering the latest research on treating cardiovascular disease during pregnancy as well as postpartum, this study discusses the indications of drug usage in pregnant women and assesses the risks and benefits of a range of therapies in the relevant population.
Klappentext zu „Cardiac Drugs in Pregnancy “
The spectrum ofcardiovascular disease affecting women in pregnancy and postpartum is changingand differs between countries. In the western world, the risk of cardiovasculardisease in pregnancy has increased due to the increasing age at the firstpregnancy and the worldwide obesity epidemic leading also to early diabetes andhypertension. In addition the treatment of congenital heart disease hasimproved leading to an increased number of women with residual heart diseasereaching childbearing age. In the western world maternal heart disease is nowthe major cause of maternal death during pregnancy. In the developing worldrheumatic heart disease and the cardiomyopathies dominate. Those women oftenneed anticoagulation as they might have had a valve replacement or formed athrombus in the left heart. Drugs during pregnancy and the breastfeeding periodis a complex subject and there is a profound shortage of evidence basedrecommendations. As drug treatment in pregnancy concern the mother and thefetus optimum treatment of both must be targeted.This book aims at discussing the most important indications of drugusage in pregnancy and postpartum with the aim of weighing the potential riskof a drug and the possible benefit against each other.
Inhaltsverzeichnis zu „Cardiac Drugs in Pregnancy “
Introduction.- General principles andguidelines.- Management of Hypertension.- Management of Heart Failure.-Management of coronary arterydisease & Arrhythmia.- Anticoagulation in Pregnancy.- Obstetric drugs inmanagement if Cardiovascular disease.- Pregnancy anaesthesia in patients withcardiovascular disease.
Autoren-Porträt
Professor Karen Sliwa-Hähnle, MD, PhD, FESC, FACC, DTM&H, is Director of the Hatter Institute for Cardiovascular Research in Africa (HICRA) and Professor at the Department of Medicine and Institute of Infectious Diseases and Molecular Medicine University of Cape Town, South Africa.Professor John Anthony, MB, ChB, FCOG, MPhil, is Head of the Department of Obstetrics & Gynaecology at Groote Schuur Hospital, Cape Town, South Africa.
Bibliographische Angaben
- 2014, Repr. d. Ausg. v. 2013, XII, 131 Seiten, 2 farbige Abbildungen, Maße: 12,7 x 20,3 cm, Kartoniert (TB), Englisch
- Herausgegeben: Karen Sliwa, John Anthony
- Verlag: Springer, Berlin
- ISBN-10: 1447154711
- ISBN-13: 9781447154716
- Erscheinungsdatum: 11.12.2013
Sprache:
Englisch
Pressezitat
"This handy book, written by distinguished authors in the field, consists of six chapters illustrating pharmacological treatment of different heart diseases during pregnancy. ... The book is an easy and enjoyable reading. ... the content is easily comprehensible and the book has a universal appeal, as it includes treatment in countries with different facilities. In addition, the pocket format is pleasing and practical for the everyday clinician." (Maria Schaufelberger, European Heart Journal, Vol. 36 (18), 2015)
Kommentar zu "Cardiac Drugs in Pregnancy"
0 Gebrauchte Artikel zu „Cardiac Drugs in Pregnancy“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Cardiac Drugs in Pregnancy".
Kommentar verfassen